Abstract
According to the statistics provided by National Bureau of Controlled Drugs in Taiwan and the United Nations International Narcotics Control Board, the DDD (Defined Daily Doses) of morphine consumption per million inhabitants in Taiwan was 12.2 mg in 1987, and substantially increased to 257.7 mg in 2002, which has been growing by 20 times in 16 years. The average daily consumption of morphine in Taiwan is one-twelfth of in United States. [1]In this study, we use the National Health Insurance Research Database (NHIRD) as our data source. The data was then pre-processed and saved into the database. We also developed an online inquiry system, which allows users to setup their own search terms and query outpatient data for follow-up analysis. In the future, we will provide more search methods by using other terms such as ICD-9 (International Statistical Classification of Diseases) for inquiries. In addition, the study will analyze not only the use of morphine and their combined drugs, but also establish Bayesian network for establishing the relationship between parameters, and analyze the effect of combined drug on morphine dosage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lu, Z.-w., Lin, C.-J., Li, J.-H., Sun, W.-Z.: Taiwan morphine consumption of 16-year trend - with Asia and the world comparison, pain. Medical journal 14(1), 1–6 (2004)
Wan-Ping, Y.: A gold drugs or medication? Opiates is a paradox of the role, Chen-Kong university health care group
Taiwan Cooperative Oncology Organization, Cancer pain management guidelines. National Institutes of Health Cancer Institute (2007)
Cleeland, C.S., Gonin, R., Hatfield, A.K., et al.: Pain and its treatment in outpatients with metastatic cancer. N. Engl. J. Med. 330, 592–596 (1994)
Portenoy, R.K., Lesage, P.: Management of cancer pain. Lancet 353, 1695–1700 (1999)
Portenoy, R.K., Payne, D., Jacobsen, P.: Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81, 129–134 (1999)
Curran, D., Fossa, S., Aaronson, N., et al.: Baseline quality of life of patients with advanced prostate cancer. Eur. J. Cancer 33, 1809–1814 (1997)
Peng, W.L., Wu, G.J., Sun, W.Z., Chen, J.C., Huang, A.T.: Multidisciplinary management of cancer pain: a longitudinal retrospective study on a cohort of end-stage cancer patients. J. Pain Symptom Manage 32, 444–452 (2006)
World Health Organization, Cancer pain relief, 2nd edn. WHO, Geneva (1996)
de Leon-Casasola, O.A.: Current developments in opioid therapy for management of cancer pain. Clin J. Pain 24, S3–S7 (2008)
Benyamin, R., Trescot, A.M., Datta, S., et al.: Opioid complications and side effects. Pain Physician 11, S105–S120 (2008)
William, L., MacLeod, R.: Management of breakthrough pain in patients with cancer. Drugs 68, 913–924 (2008)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rau, HH., Tang, WT., Hsu, CY. (2009). Advanced Analysis Information Architecture for Dosage Evaluation of Morphine Combining Adjunct. In: Ślęzak, D., Arslan, T., Fang, WC., Song, X., Kim, Th. (eds) Bio-Science and Bio-Technology. BSBT 2009. Communications in Computer and Information Science, vol 57. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-10616-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-10616-3_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-10615-6
Online ISBN: 978-3-642-10616-3
eBook Packages: Computer ScienceComputer Science (R0)